case_images: PMC7330645_01
case_images: Pelvic CT showed inflammation spread and abscess formation around the cecum (a). Abdominal CT showed a huge mass and multiple nodules in the liver (b). Chest CT showed nodules in the lungs (c). Arrows: lesions.
case_images: CRIONM2020-2351810.001.jpg
case_images: PMC7330645_01_CRIONM2020-2351810.001.jpg
case_images: fig1
case_images: Computed tomography (CT) scan of the abdomen and pelvis showed inflammation spread, abscess formation, lymphadenopathy around the cecum, and a huge mass with multiple nodules in the liver (Figures 1(a) and 1(b)). A chest CT also revealed multiple pulmonary nodules (Figure 1(c)).
case_images: Abdominal and chest CT before the administration of S-1 (a, b). Stable disease after therapy (c, d). Arrows: lesions in the liver.
case_images: CRIONM2020-2351810.002.jpg
case_images: PMC7330645_01_CRIONM2020-2351810.002.jpg
case_images: fig2
case_images: Therefore, we readministered the 5-FU oral preparation S-1 (80 mg/m2, Days 1-28, 42-day cycle), which provided a 7-month SD period (Figure 2).
case_images: Abdominal and chest CT before the administration of panitumumab (a, b). Stable disease after therapy (c, d). Pulmonary metastasis was slightly reduced after panitumumab treatment. Arrows: lesions in the liver.
case_images: CRIONM2020-2351810.003.jpg
case_images: PMC7330645_01_CRIONM2020-2351810.003.jpg
case_images: fig3
case_images: The patient achieved SD on this regimen for 7.5 months (Figure 3).